|
|||||
|
|
Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3 |
|
| Authors: | Martínez-López Joaquín Castro Nerea Rueda Daniel Canal Alicia Grande Carlos Ayala Rosa |
| Affiliation: | 1. Oxford Radcliffe Hospitals NHS Trust;2. Royal Berkshire Hospitals NHS Foundation Trust;3. Kings College Hospital NHS Foundation Trust;4. Kings College London, London, UK. E‐mail: kramasamy@nhs.net |
| Abstract: | |
| Keywords: | myeloma myeloma therapy multiple myeloma |
| 本文献已被 PubMed 等数据库收录！ | |